RECODE-DCM Newsletter Highlights (June 2023)

Welcome to the RECODE-DCM network! Myelopathy.org is leading the fight for people with Degenerative Cervical Myelopathy (DCM), to build a world where people can live their lives free of the life-limiting impact of DCM and have a healthy, active, and…
BritSpine 2023: Making Myelopathy.org Memorable to Spine Care Professionals

The future for Degenerative Cervical Myelopathy (DCM) looked bright in the Glasgow sunshine at BritSpine 2023! This international conference, held at the Scottish Event Campus from April 18-20, attracted over 600 delegates across the spine care profession. The UK Spine…
RECODE-DCM Newsletter Highlights (April 2023)

Welcome to the RECODE-DCM Network! Myelopathy.org, the only charity shining a light on Degenerative Cervical Myelopathy (DCM), welcomes you to RECODE-DCM. Our multidisciplinary think tank is catalysing patient-directed research into the world’s number one cause of spinal cord injury in adults. Making Myelopathy…
2023 Myelopathy.org Research Awards Open

On 31 March 2023 Myelopathy.org will open entries for its 2023 Research Award for best piece of research aligned with a RECODE-DCM Top 10 Research Priority: The award (and £200 prize money!) will be given to the author of the…
Announcing 2022 Myelopathy.org Research Award Winner

Myelopathy.org is delighted to announce the winner of its inaugural Research Award for best piece of research aligned with a RECODE-DCM Top 10 Research Priority: Dr Michael G Fehlings from Toronto, Canada for his paper, The influence of ApoE4 on the…
RECODE-DCM Newsletter Highlights (January 2023)

Thank you for being part of the RECODE-DCM community Myelopathy.org, the first global scientific and clinical charity dedicated to positively transforming patient outcomes in Degenerative Cervical Myelopathy (DCM), welcomes you to RECODE-DCM, the research arm of the charity. DCM is…
Launching RECEDE-Myelopathy, the World’s First Regenerative Medicine Trial for DCM
Principal Investigator Dr Mark Kotter and Co-Principal Investigator Dr Ben Davies are excited to announce the launch of the first regenerative medicine trial for Degenerative Cervical Myelopathy (DCM) at Cambridge University Hospitals. RECEDE-Myelopathy is a phase 3, double blind, randomised…
RECODE-DCM Newsletter (October 2022)

Welcome to the RECODE-DCM Network! Myelopathy.org, the first global scientific and clinical charity dedicated to positively transforming patient outcomes in Degenerative Cervical Myelopathy (DCM), welcomes you to RECODE-DCM. This initiative started as a partnership with AO Spine, to develop a ‘research…
Myelopathy.org Inspires Prize-Winning Research

Myelopathy.org is receiving entries for its inaugural research award for best piece of research aligned with a RECODE-DCM Top 10 Research Priority: Raising Awareness of Degenerative Cervical Myelopathy (DCM) Natural History Diagnostic Criteria Assessment and Monitoring Biological Basis Peri-Operative Rehabilitation Novel…
AO Spine RECODE-DCM

Quarterly Newsletter, June 2022 AO Spine RECODE-DCM aims to accelerate research to improve outcomes in DCM. By bringing those who live with DCM together with those who treat it, our international multi-disciplinary collaboration is closing knowledge gaps. AO Spine RECODE-DCM…
